Name | Symbol | Markt | Aktientyp |
---|---|---|---|
Nymox Pharmaceutical Corp | NYMX | NASDAQ | Common Stock |
Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
---|---|---|---|---|
0,20 |
Aktuelle News
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
28.3.2024 | 18:03 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
06.11.2023 | 15:59 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
08.9.2023 | 16:13 | EDGAR2 | Form 25-NSE - Notification filed by national security.. |
25.7.2023 | 22:04 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
25.7.2023 | 16:33 | GLOBE | Nymox Reports Successful New NYMOZARFEX (TM) Long-Term.. |
18.7.2023 | 16:45 | GLOBE | Nymox Reports on U.S. Patent Issuances |
13.7.2023 | 16:16 | GLOBE | Nymox Update |
12.7.2023 | 15:30 | GLOBE | Nymox Announces Appointment Of Patrick Doody as Vice.. |
07.7.2023 | 23:02 | GLOBE | NYMOX Update |
06.7.2023 | 00:11 | GLOBE | Nymox Delisting from NASDAQ |
29.6.2023 | 23:15 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
10.5.2023 | 16:00 | GLOBE | Nymox Provides Current Update |